Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sensipar for Hypercalcemia in Renal Transplant Recipients
NCT00975000Phase 3Completed
- Sponsor
- Amgen
- Start
- Dec 2009
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of cinacalcet in hypercalcemia, hyperparathyroidism, sponsored by Amgen. Started Dec 2009; status: completed.
02
Drugs
cinacalcet
03
Conditions
hypercalcemiahyperparathyroidism
Beyond the preview
Go deeper on NCT00975000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00975000.